Diabetes Drugs

Microdosing is the off-label use of GLP-1 medications at lower than approved doses for diabetes or weight management. There are numerous reasons people may consider microdosing, including cost savings and minimizing side effects.

Results from recent clinical trials suggest that retatrutide, a first-of-its-kind experimental drug, causes unprecedented levels of weight loss. Its effects on blood sugar for diabetes are comparable to currently available GLP-1 drugs like Ozempic. 

Insurance issues and side effects are some of the reasons people need to stop taking a GLP-1 drug for diabetes or weight management. Here’s how to navigate the transition and protect your health.

GLP-1 drugs were once met with skepticism, but now their proven health benefits have brought them unprecedented levels of hype. Researchers talked about how we got here and what they hope to see next for these life-changing medications.

GLP-1 medications are very effective for weight management, but can also cause muscle loss. People who use them – or really any weight loss strategy – should prioritize maintaining their muscle health. Nutrition and regular exercise are key to building and maintaining strength while losing weight.

The American Diabetes Association recently released its 2026 Standards of Care, which includes new recommendations on diabetes technology, therapy, and preventative health.